Pharmacokinetic non-interaction analysis in a fixed-dose formulation in combination of atorvastatin and ezetimibe

Recent clinical research has shown that atorvastatin (ATO) in combination with cholesterol absorption inhibitor ezetimibe (EZE) significantly reduces LDL-C level in patients with hypercholesterolemia, showing a superior lipid-lowering efficacy compared to statin alone. With no information currently...

Descripción completa

Detalles Bibliográficos
Autores principales: Patiño-Rodríguez, Omar, Torres-Roque, Irma, Martínez-Delgado, Maricela, Escobedo-Moratilla, Abraham, Pérez-Urizar, José
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2014
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4245888/
https://www.ncbi.nlm.nih.gov/pubmed/25505887
http://dx.doi.org/10.3389/fphar.2014.00261

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4245888/
https://www.ncbi.nlm.nih.gov/pubmed/25505887
http://dx.doi.org/10.3389/fphar.2014.00261

Ejemplares similares